Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about AbbVie Inc

Recent news which mentions AbbVie Inc

< Previous 1 2 Next >
Cramer's week ahead: Earnings from Tesla, Alphabet, Capital One and Boeing
Tags Investment Strategy Delta Air Lines Inc Alphabet Inc
From CNBC.com News
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
Tags US: News Bristol/Myers Squibb Co LILLY DRN
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags Johnson & Johnson Breaking News: Markets Biotech and Pharmaceuticals
From CNBC.com News
Ad spending on women's sports more than doubled last year
Tags Business News Nike Inc Restaurant Brands International Inc
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Novo Nordisk A/S Structure Therapeutics Inc Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lighting Round: AbbVie is a buy
Tags Coinbase Global Inc U/S/ Markets Cerence Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Theravance Biopharma Inc Pfizer Inc Health care industry
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
Tags stocks Trump Media & Technology Group Corp Meta Platforms Inc
From CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
Tags Investment Strategy Core Scientific Inc GXO Logistics Inc
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Universal Health Services Inc Walmart Inc Brown & Brown Inc
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Bristol/Myers Squibb Co Eli Lilly and Co US: News
From CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
Tags Health & Science Politics Abbvie Inc
From CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
Tags Abbvie Inc Health & Science Teva Pharmaceutical Industries Ltd
From CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
Tags Business Abbvie Inc Biotechnology
From CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
Tags Technology Space industry Breaking News: Technology
From CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
Tags Stock Picks Business News Freeport/McMoRan Inc
From CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
Tags Pharmaceuticals Biotech and Pharmaceuticals Johnson & Johnson
From CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
Tags Pharmaceuticals Biotech and Pharmaceuticals Johnson & Johnson
From CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
Tags Investment Strategy JPMORGAN DRN Cerevel Therapeutics Holdings Inc
From CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
Tags Biotech and Pharmaceuticals Pharmaceuticals BioNTech SE
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags 5 Things to Know Investment strategy Citigroup Inc
From CNBC.com News
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
Tags Health & Science Companies Biotechnology
From CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Tags US: News ADC Therapeutics SA Acquisitions
From CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
Tags CNBC Investing Club Markets CNBC Investing Club: Newsletter
From CNBC.com News
Cramer's Lightning Round: Energy Transfer is a buy
Tags Salesforce Inc Stock markets Market Outlook
From CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
Tags Merck & Co Inc Amgen Inc Breaking news
From CNBC.com News
Federal judge declines to block Medicare price negotiations
Tags AstraZeneca PLC Health care industry Lawsuits
From CNBC.com News
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
Tags Business Abbvie Inc Biotechnology
From CNBC.com News
CVS pushes further into generic drugs with Sandoz partnership for new discount Humira
Tags Novartis AG Health care industry CVS Health Corp
From CNBC.com News
These 10 medications are likely targets for Medicare price negotiations this fall
Tags Johnson & Johnson Business News Breaking News: Business
From CNBC.com News
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.